World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 14 November 2022
Main ID:  NCT03464175
Date of registration: 04/03/2018
Prospective Registration: No
Primary sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Public title: Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation Aerovent-
Scientific title: Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation: a Randomized Comparative Scintigraphic Study
Date of first enrolment: January 22, 2018
Target sample size: 34
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03464175
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Belgium
Contacts
Name:     Pierre-François Laterre, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Cliniques universitaires Saint-Luc
Key inclusion & exclusion criteria

Inclusion Criteria:

- Aged 18 years or older

- Postoperative neurosurgery intubated patients admitted for brain neurosurgery in the
ICU (Intensive care neuro-traumatologic and Toxicologic)- With a healthy lung
function.

- Signed and dated informed consent should be obtained in accordance of local
regulations.

Exclusion Criteria:

- Spine neurosurgery

- History of cardiovascular and pulmonary disease

- Extubation immediately after surgery

- Modification of the allocated humidification technique before or during the
nebulization (heated-humidifier deficiency or safety concern)

- Inaccurate quantification of aerosol deposition (i.e., artifacts or overlap of
tracheal and pulmonary deposition).



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Brain Injuries, Traumatic
Intervention(s)
Device: Conventional dry ventilator circuit with HME filter
Device: Aerogen Solo®
Device: Dry ventilator circuit specific for aerosol therapy
Device: Heated-humidified circuit
Primary Outcome(s)
Quantity of aerosol deposition from the nebulizer reservoir to the subject. Measured by Planar scintigraphy. [Time Frame: 45 minutes]
Secondary Outcome(s)
Secondary ID(s)
2017/08NOV/508
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history